Status:
SUSPENDED
Computer - Based Treatment for Social Anxiety Disorder
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
Columbia University
Mclean Hospital
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The present study is a controlled trial that seeks to examine the feasibility, acceptability, mechanism, and efficacy of a recently developed computer-based therapy in individuals with social anxiety ...
Detailed Description
This randomized clinical trial examines the feasibility, acceptability, mechanism, and relative efficacy of two forms of a recently developed 4-week/8-session computer-based therapy in individuals wit...
Eligibility Criteria
Inclusion
- Males and females between the ages of 18 to 60
- Current primary diagnosis of SAD
- Score of at least 50 on the Liebowitz Social Anxiety Scale (self-rated version)
- Fluent in English
- Willing and able to give informed written consent
- Ability to participate responsibly in the protocol
- Normal or corrected-to-normal vision
Exclusion
- Present or past psychotic episode, psychotic disorder, schizophrenia, schizoaffective disorder, or bipolar disorder
- Current severe depression
- Suicidal ideation or behavior
- Current diagnosis of post-traumatic stress disorder, obsessive-compulsive disorder, bipolar disorder, manic episode or tic disorder
- Current or past organic mental disorder, seizure disorder, epilepsy or brain injury
- Current unstable or untreated medical illness
- Severe alcohol use disorder, severe cannabis use disorder, and any severity of other substance use disorder (except nicotine use disorders)
- Use of psychiatric medication in the past month other than a stable dose of selective serotonin reuptake inhibitors (SSRIs) for at least 3 months
- Any concurrent cognitive behavioral therapy or other psychotherapy that was initiated in the past 3 months
- Pregnancy, or plans to become pregnant during the period of the study (will be assessed by urine)
- Contraindication to MRI scanning (Paramagnetic metallic implants or devices contraindicating magnetic resonance imaging or any other non-removable paramagnetic metal in the body)
- pacemaker
- paramagnetic metallic prosthesis
- surgical clips
- shrapnel
- necessity for constant medicinal patch
- some tattoos
- Inability to tolerate MRI scanning procedures (i.e., severe obesity, claustrophobia)
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04663724
Start Date
February 15 2021
End Date
February 28 2027
Last Update
February 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1051 Riverside Drive
New York, New York, United States, 10032